Skip to main content
Skip to main content
GEG logo

Great Elm Group, Inc. (GEG) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$2.20 -$0.02 (-0.90%)
MCap: $69.0M| Vol: 5.4K| 52-wk range: $1.80 – $3.03

Market cap $69.0M is the value of all shares combined. Beta 0.53: the stock has moved about 47% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Great Elm Group, Inc. (GEG) trades at $2.20. Great Elm Group, Inc. operates in the healthcare sector, focusing on durable medical equipment distribution and investment management. Market cap: $69.0M, Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: May 10, 2026
Great Elm Group, Inc. operates in the healthcare sector, focusing on durable medical equipment distribution and investment management. The company provides respiratory care equipment and investment services, targeting specific healthcare needs and financial opportunities.

Analyst Coverage for GEG: GEG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GEG against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the GEG film Every key number, told as a short cinematic story — just press play. ~2 min

Great Elm Group, Inc. (GEG) Healthcare & Pipeline Overview

CEOJason W. Reese
Employees52
HeadquartersWaltham, MA, US
IPO Year1999

Great Elm Group, Inc. (GEG) distributes durable medical equipment, including respiratory care devices, and offers investment management services. Operating within the healthcare sector, the company provides essential medical equipment and financial solutions, distinguishing itself through a dual focus on healthcare distribution and investment management.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for GEG?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Great Elm Group, Inc. presents a mixed investment profile. The company's involvement in both durable medical equipment distribution and investment management provides diversification. However, the company's negative profit margin of -100.5% raises concerns about profitability. A beta of 0.53 suggests lower volatility compared to the market. Growth catalysts include potential expansion of its respiratory care equipment distribution and increased demand for investment management services. The company's small market capitalization of $69.0M indicates it is a micro-cap stock, which can be subject to higher volatility and liquidity risks. Investors should closely monitor the company's ability to improve its profit margins and capitalize on growth opportunities in its target markets.

Based on FMP financials and quantitative analysis

GEG Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $69.0M, indicating a micro-cap stock.

  • Negative profit margin of -100.5%, reflecting significant losses.
  • Gross margin of 3.1%, suggesting limited profitability from sales.
  • Beta of 0.53, indicating lower volatility compared to the overall market.
  • No dividend yield, as the company does not currently distribute dividends.

Who Are GEG's Competitors?

GEG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
ACH Accendra Health, Inc. $1.08 +0.93% $82.7M
HX Akso Health Group $2.24 -4.27% $53.4M
OMI Owens & Minor, Inc. $2.68 +8.94% $207M
WGRX Wellgistics Health, Inc. $3.52 0.00% $8.67M
ARRJF Arjo AB (publ) $2.85 -0.52% $776M 439-signal
MEDOF Medios AG $50.00 0.00% $1.28B 459-signal
PBH Prestige Consumer Healthcare Inc. $47.34 -2.79% $2.24B 625-pillar
PDCO Patterson Companies, Inc. $31.33 -0.90% $2.77B

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are GEG's Key Strengths?

Diversified business model with healthcare and investment management segments.

  • Established distribution network for durable medical equipment.
  • Expertise in respiratory care equipment and sleep study services.
  • Long-standing presence in the market since 1994.

What Are GEG's Weaknesses?

Negative profit margin indicates financial challenges.

  • Small market capitalization increases volatility and liquidity risks.
  • Reliance on specific geographic markets.
  • Limited brand recognition compared to larger competitors.

What Could Drive GEG Stock Higher?

Expansion into new geographic markets to diversify revenue streams (2027-2029).

  • Strategic partnerships with healthcare providers to enhance market reach.
  • Increasing demand for sleep study services due to rising awareness of sleep disorders.
  • Growing assets under management (AUM) by attracting new clients and expanding service offerings within investment management.

What Are the Key Risks for GEG?

Financial-distress signal — its Altman Z-Score of -39.51 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-38.3%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 8 of the last 8 reported quarters.
  • Negative profit margin indicates financial challenges.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturns affecting investment management performance.
  • Supply chain disruptions impacting the availability of medical equipment.
  • Intense competition from established DME distributors and investment management firms.

What Are the Growth Opportunities for GEG?

  • Expansion of Respiratory Care Equipment Distribution: The increasing prevalence of respiratory diseases, such as COPD and sleep apnea, drives demand for respiratory care equipment. Great Elm Group can expand its distribution network and product offerings to capture a larger share of this market. The global respiratory care devices market is projected to reach $30 billion by 2028, offering substantial growth potential. Timeline: Ongoing.
  • Increased Demand for Sleep Study Services: The growing awareness of sleep disorders and their impact on health is increasing demand for sleep study services. Great Elm Group can expand its sleep study service offerings and partnerships with healthcare providers to capitalize on this trend. The sleep apnea diagnostics and therapeutics market is expected to reach $5 billion by 2027. Timeline: Ongoing.
  • Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, clinics, and home healthcare agencies can enhance Great Elm Group's market reach and service delivery. These partnerships can provide access to a broader patient base and streamline the distribution of medical equipment. Timeline: Ongoing.
  • Geographic Expansion: Expanding into new geographic markets can diversify Great Elm Group's revenue streams and reduce reliance on specific regions. Identifying underserved markets with a high demand for durable medical equipment can provide significant growth opportunities. Timeline: 2027-2029.
  • Investment Management Service Expansion: Growing assets under management (AUM) by attracting new clients and expanding service offerings within investment management can significantly boost revenue. Focusing on niche investment strategies and personalized client services can differentiate Great Elm Group in the competitive investment management industry. Timeline: Ongoing.

What Are GEG's Competitive Advantages?

  • Established distribution network for durable medical equipment.
  • Expertise in respiratory care equipment and sleep study services.
  • Dual focus on healthcare and investment management provides diversification.
  • Long-standing relationships with healthcare providers.

What Does GEG Do?

Great Elm Group, Inc., established in 1994 and headquartered in Waltham, Massachusetts, operates within the healthcare and financial sectors. Originally known as Great Elm Capital Group, Inc., the company rebranded in December 2020 to better reflect its diversified business model. The company's durable medical equipment (DME) segment focuses on the distribution of respiratory care equipment, including positive air pressure (PAP) devices, ventilators, oxygen equipment, and related replacement parts. Additionally, Great Elm Group provides sleep study services and rents medical equipment to cater to a broad range of patient needs. Complementing its healthcare operations, the company offers investment management services, leveraging its financial expertise to manage assets and generate returns. This dual approach allows Great Elm Group to serve both the healthcare market and the investment community, positioning it as a versatile player in its respective industries. The company aims to provide comprehensive solutions by integrating medical equipment distribution with financial management services.

What Products and Services Does GEG Offer?

  • Distributes respiratory care equipment, including PAP devices and ventilators.
  • Provides oxygen equipment and related replacement parts.
  • Offers sleep study services to diagnose sleep disorders.
  • Rents medical equipment to patients.
  • Provides investment management services to clients.
  • Focuses on durable medical equipment (DME) distribution.

How Does GEG Make Money?

  • Generates revenue through the sale and rental of durable medical equipment.
  • Earns fees from providing sleep study services.
  • Manages investments for clients, earning management and performance fees.

What Industry Does GEG Operate In?

Great Elm Group, Inc. operates in the durable medical equipment (DME) distribution and investment management industries. The DME market is driven by an aging population and increasing prevalence of chronic respiratory diseases. The investment management industry is influenced by market conditions and investor sentiment. Great Elm Group's competitors include specialized DME distributors and larger investment management firms. The company's ability to differentiate itself through specialized services and efficient operations will be crucial for success in these competitive landscapes.

Who Are GEG's Key Customers?

  • Patients requiring respiratory care equipment.
  • Hospitals and clinics needing medical equipment.
  • Individuals seeking sleep study services.
  • Investors seeking investment management services.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 85/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 16 days ago
  • No analyst coverage
  • This is an unknown, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 24
2026-08-26 24
2026-08-29 24
2026-09-01 24
2026-09-04 24
2026-09-07 24
2026-09-10 24

What changed?

The score has stayed at 24.

What moved it up or down:

  • +2 Growth Durability

Over the same 18 days the stock moved +2.3%.

Great Elm Group, Inc. (GEG) Valuation Context

Valued at $69.0M, GEG is classified as a micro-cap stock.

GEG Revenue & Earnings Trend

In Q4 FY2026, GEG generated $10.6M in top-line revenue, marking a sequential increase of 208.9%. The company recorded net income of $1.1M, with diluted EPS of $0.04. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this micro-cap Healthcare company. Across the four most recent quarters, GEG averaged $-0.29 in diluted EPS.

Company Profile

Great Elm Group, Inc. operates in the Asset Management industry within the Financial Services sector. It is headquartered in Palm Beach Gardens, US. The company is led by CEO Jason Walter Reese. GEG has traded publicly since 1999.

ROE -38%

Key Financial Metrics

Return on equity for Great Elm Group, Inc. stands at -38.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -20.5%, showing how much profit it generates from its asset base. Its free cash flow yield is 17.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 13.18 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -34.7%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 4/9

Financial Health

Great Elm Group, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -39.51 places it in the distress zone, a signal of elevated financial risk.

0/8 beats

Earnings Track Record

Great Elm Group, Inc. has missed Wall Street's EPS estimate in 8 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 102.2% below estimates on average.

Net selling

Insider Activity

Over the past six months, Great Elm Group, Inc. insiders filed 5 SEC Form 4 transactions — 3 sales and 2 purchases. On net that is roughly 100K shares disposed (about $0), a signal worth weighing alongside the fundamentals.

GEG Financials

Fundamental Snapshot

Revenue Growth (FY)
+70.2%
Net Income Growth (FY)
-375.0%
EPS Growth (FY)
-348.9%
Free Cash Flow Growth (FY)
+231.9%
Return on Equity (TTM)
-38.3%
Current Ratio
13.2

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • Diversified business model with healthcare and investment management segments.
  • Established distribution network for durable medical equipment.
  • Expertise in respiratory care equipment and sleep study services.
  • Long-standing presence in the market since 1994.

Bear Case

  • Negative profit margin indicates financial challenges.
  • Small market capitalization increases volatility and liquidity risks.
  • Reliance on specific geographic markets.
  • Limited brand recognition compared to larger competitors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 FY2026 $11M $1M $0.04
Q3 FY2026 $3M -$14M -$0.45
Q2 FY2026 $3M -$16M -$0.50
Q1 FY2026 $11M -$7M -$0.24

Q4 FY2026 · filed 26 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

GEG Latest News

GEG Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GEG.

Price Targets

Wall Street price target analysis for GEG.

GEG MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GEG; grades run from A+ (80-100) to F (below 30).

Leadership: Jason W. Reese

CEO

Jason W. Reese serves as the CEO of Great Elm Group, Inc. His background includes extensive experience in investment management and corporate strategy. Prior to his role at Great Elm Group, Reese held leadership positions in various financial services firms, focusing on portfolio management and business development. He brings a wealth of knowledge in capital allocation and strategic planning to the company.

Track Record: Under Jason W. Reese's leadership, Great Elm Group, Inc. has focused on expanding its durable medical equipment distribution network and enhancing its investment management services. Key milestones include the rebranding of the company in December 2020 and efforts to improve operational efficiency. Reese has been instrumental in navigating the company through challenging market conditions and positioning it for future growth.

What Investors Ask About Great Elm Group, Inc. (GEG) — Healthcare

Is GEG a good stock?

Stock Expert AI does not rate GEG buy, sell or hold. Great Elm Group, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about GEG stock?

Analyst coverage of Great Elm Group, Inc. (GEG) is limited due to its small market capitalization. Key valuation metrics include its market cap of $69.0M and a negative profit margin of -100.5%.

What are the key factors to evaluate for GEG?

Evaluate GEG on fundamentals, analyst consensus, and risk factors. Great Elm Group, Inc. presents a mixed investment profile. Not financial advice.

How frequently does GEG data refresh on this page?

GEG's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven GEG's recent stock price performance?

Great Elm Group, Inc. (GEG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model with healthcare and investment management segments. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider GEG overvalued or undervalued right now?

Great Elm Group, Inc. (GEG) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of GEG?

Yes, most major brokerages offer fractional shares of Great Elm Group, Inc. (GEG) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track GEG's earnings and financial reports?

Great Elm Group, Inc. (GEG) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for GEG earnings announcements.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • Analyst coverage is limited due to the company's small market capitalization.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover